Fitness & Wearable Tech — 2026-05-29
Samsung's Galaxy Watch 9 and Ultra 2 are rumored to debut in July with 5G and potential glucose sensing, while Strava launches a major strength-training overhaul with muscle maps and 14 device integrations. Google's rebranded Health app (formerly Fitbit) rolls out this week with AI-powered coaching features, signaling a broader industry shift toward AI-driven recovery and gym tracking.
Fitness & Wearable Tech — 2026-05-29
Wearable Hardware
Samsung Galaxy Watch 9 and Ultra 2
- Brand: Samsung
- What's new: Upcoming smartwatches rumored for July launch with 5G connectivity and possible glucose sensor integration
- Why it matters: Glucose monitoring on mainstream smartwatches would expand health sensing beyond heart rate and activity tracking, bringing Samsung closer to medical-grade diagnostics on consumer wearables
Garmin 2026 Smartwatch Updates Rolling Out
- Brand: Garmin
- What's new: First 2026 software update now rolling out to select Venu and Vivoactive models with health and fitness improvements
- Why it matters: Staged rollout demonstrates Garmin's continued commitment to iterative device improvements and feature parity across its popular fitness watch lineup
Google Fitbit Air Recognition
- Brand: Google
- What's new: Google's screenless Fitbit Air band continues to gain recognition as a top fitness tracker for 2026
- Why it matters: The form factor shift away from screens toward minimalist health bands reflects industry trends toward passive monitoring and reduced user friction
Apps & Platforms
Strava Strength Training Expansion
- Update: Complete overhaul of strength training experience with new workout log, automatic muscle maps showing which muscle groups were targeted, and 14 integrations including Garmin, WHOOP, COROS, and Hevy
- Who benefits: Gym-goers and strength athletes who want to log lifts alongside cardio and receive unified performance insights across wearables and workout apps
Google Health App Launch
- Update: Fitbit app rebrands to Google Health app this week (rollout May 26) with four-tab layout redesign and Gemini-powered Google Health Coach for AI-driven fitness guidance
- Who benefits: Fitbit device owners and Google Health ecosystem users seeking integrated AI coaching alongside passive health tracking
Health Sensing & Research
-
FDA Guidance on Wellness Wearables: FDA clarified broader wellness exemptions for blood pressure and blood glucose wearables in early 2026, provided values are validated and intended solely for wellness purposes. As of March 2026, no new FDA clearances for mainstream consumer wearables in heart monitoring, glucose, or sleep apnea have been issued since August 2025, indicating regulatory caution alongside industry advancement.
-
Clinical-Grade Utility Emerging: Wearable health monitoring in 2026 is transitioning from novelty to clinical-grade utility, with the biggest advances being smarter data algorithms, FDA-cleared decision support, and devices integrating into clinical workflows rather than just consumer apps.
Weekly Analysis
The week reveals a clear industry bifurcation: premium brands like Samsung and Garmin are iterating on existing form factors with incremental sensor and software upgrades, while platform players like Google and Strava are winning by expanding beyond pure running*. Strava's strength-training pivot—backed by 14 integrations—signals that workout apps are now fighting for the untapped gym market, where runners have owned the space for a decade. Google's Health Coach rebranding positions AI as the new differentiator, echoing Apple's AI Workout Buddy and Fitbit's beta AI coach. Meanwhile, glucose sensing on smartwatches (Samsung's rumored move) remains regulatory theater: validation and wellness positioning matter more than the sensor itself. The competitive pressure is intensifying, but the real winners this week are ecosystem players who can stitch wearables, apps, and AI into seamless workflows.
What to Watch Next Week
- Samsung Galaxy Unpacked Event (July 2026): Expected reveal of Galaxy Watch 9 and Ultra 2 with confirmed specs on 5G and glucose monitoring capabilities
- FDA regulatory updates on wearable clearances: Watch for Q2 2026 summary of any new 510(k) or Class II clearances for continuous glucose, blood pressure, or SpO₂ devices targeting mainstream consumer markets
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
